trending Market Intelligence /marketintelligence/en/news-insights/trending/-cu1R2BuePOhoX2Ugebv1Q2 content esgSubNav
In This List

TransEnterix approves a planned reverse stock split at 1-for-13 ratio

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


TransEnterix approves a planned reverse stock split at 1-for-13 ratio

TransEnterix Inc. specified and approved a reverse stock split of its shares at a 1-for-13 ratio, effective Dec. 11.

Trading of the Morrisville, N.C.-based medical device company's shares will continue on a split-adjusted basis Dec. 12. The company will continue to trade on the New York Stock Exchange under the ticker TRXC post-split.

Following the reverse stock split, fractional shares will round up to a full share for the stockholders who hold them.